Growth | Page 67 of 99 | SpiritIndia.com

Overweight :: Overweight girls at risk for cardiovascular disease

Results from the NHLBI Growth and Health Study of more than 2,300 girls suggest that girls as young as age 9 who are overweight are at increased risk for short-term and long-term problems that increase the chances of developing cardiovascular disease. Those who were overweight were more likely to have elevated blood pressure and cholesterol levels compared to girls who were not overweight. The study also provides insight into differences between African-American and Caucasian girls.

Stem Cell :: Amniotic fluid new source of stem cells

Scientists have discovered a new source of stems cells and have used them to create muscle, bone, fat, blood vessel, nerve and liver cells in the laboratory. The first report showing the isolation of broad potential stem cells from the amniotic fluid that surrounds developing embryos was published today in Nature Biotechnology.

Encephalopathy :: Ashley Treatment – towards a better quality of life for Pillow Angels

Ashley had a normal birth, but her mental and motor faculties did not develop. Over the years, neurologists, geneticists, and other specialists conducted every known traditional and experimental test, but still could not determine a diagnosis or a cause. Doctor?s call her condition ?static encephalopathy of unknown etiology?, which means an insult to the brain of unknown origin or cause, and one that will not improve.

Ovarian Cancer :: Ovarian Cancer’s new medicine with positive results

Genentech, Inc. (NYSE: DNA) announced encouraging results from a randomized Phase II study comparing pertuzumab plus gemcitabine to gemcitabine alone in women with platinum-resistant ovarian, primary peritoneal, or fallopian tube cancer. Data from the study will be submitted for presentation at an upcoming medical meeting.

Liver Cancer :: No benefit for liver cancer patients from long-acting octreotide

Long-acting octreotide does not improve outcomes for patients with liver cancer compared to a placebo, according to the results of a new double blind study published in the January 2007 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).

Neuroscience :: News tips from the Journal of Neuroscience

The following articles will be featured in the upcoming issue of the Journal of Neuroscience: “Recruiting Secretory Vesicles with DAG and Munc13-1”; “DISC1 Complexes in Axonal Elongation”; “Sweet and Sweetener Units”; and “Endocannabinoid Signaling and Febrile Seizures.”

Down Syndrome :: Down syndrome screening test for younger pregnant women

All pregnant women should be offered screening for Down syndrome in their first trimester, according to new practice guidelines to be issued by the American College of Obstetricians and Gynecologists. This is applicable to younger pregnant women regardless of their age.

Hemophilia :: Spleen tissue transplant cures hemophilia

In hemophilia, a mutated gene prevents the production of a blood-clotting protein. Treatments for hemophilia and other genetic diseases may consist of risky blood transfusions or expensive enzyme replacement therapy. But what if the body could be induced to begin producing these proteins by transplanting healthy tissue with the abilities that are lacking? The Weizmann Institute’s Immunology Department showed how such a transplant might be made feasible.

Cancer :: New drug targets for cancer therapies

Solving a 100-year-old genetic puzzle, researchers at the UCSD School of Medicine have determined that the same genetic mechanism that drives tumor growth can also act as a tumor suppressor. Their findings could lead to new drug targets for cancer therapies.

Systemic Sclerosis :: New treatment hope for systemic sclerosis

Experiments indicate the promise of imatinib mesylate to prevent tissue fibrosis and bring meaningful advances to the treatment of SSc.